Trial Profile
Study of liraglutide, sitagliptin and insulin glargine added to standard therapy on left ventricular function in post-ischemic type-2 diabetes mellitus patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin glargine; Metformin; Sitagliptin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jul 2018 New trial record